+86 21 2215 7611 228 Weihai road • 16F Merchant Plaza • SHANGHAI 200041 • CHINA 

WuXi PharmaTech manufactures ImmuFact IMP321


The French biopharmaceutical company Immutep S.A and Eddingpharm started the production of their ImmuFact IMP321 product in WuXi AppTec facilities according to European, US and Chinese GMP standards.

Immutep will technically support the development of the production of the anti-cancer drug and was, as well as Eddingpharm, very satisfied by the Chinese manufacture’s quality as Dr. Triebel, Medical Director of Immutep said: ‘We have been very impressed by WuXi’s know how and motivation’.

Source: First Word Pharma                                                      Publication Date: 2014-04-11